Every offer you will ever receive comes out of a single calculation: what a buyer can pay today, plus what it will cost to keep the policy in force until the insured dies, so that the death benefit produces their required rate of return. There are only four variables in it — the death benefit, the projected life expectancy, the cost of carrying the policy, and the buyer’s target return — and knowing which of those you can influence is the difference between accepting the first number and getting a real one.
The one you can actually move is the third. Most policyholders have never asked their carrier for an in-force illustration showing the minimum premium required to keep the policy alive, and that figure is frequently thousands of dollars a year below what they have been paying. Because carrying cost is subtracted directly from what a buyer can bid, a policy that can be carried cheaply is worth materially more than an identical policy that cannot. Getting that illustration is the highest-value thing you can do before shopping anything, and it takes one phone call and two to four weeks.
Pine Lake Legacy provides education and a free policy review. We do not purchase policies and are not licensed in every state. Nothing here is legal, tax, or investment advice.
In This Article
- The Calculation, Written Out
- Input One: Life Expectancy, and Why It Dominates
- Input Two: Carrying Cost, the Variable You Control
- Input Three: The Net Death Benefit, Not the Face Amount
- Input Four: The Buyer’s Required Return
- What This Means for Your Own Policy
- Every Alternative Priced Against the Offer — and When Not to Sell
- Frequently Asked Questions
The Calculation, Written Out
A buyer is buying a stream of cash flows: money out today (the purchase price and transaction costs), money out every year thereafter (premiums), and money in once (the net death benefit). They solve for the purchase price that makes the internal rate of return on that stream hit their hurdle.
Because the death benefit is fixed and the timing is uncertain, the entire model runs probabilistically. The buyer does not assume the insured dies in month 84. They run a mortality curve — a probability of death in each future month — and calculate a probability-weighted return across every path. That is why an offer is not “face amount minus premiums discounted at X.” It is an expected value across hundreds of scenarios.
Three consequences follow, and they explain most of what confuses sellers. First, a small change in projected life expectancy moves the price a great deal, because it changes both when the benefit arrives and how many premiums get paid. Second, high carrying costs hurt twice — they reduce cash flow and they extend how long the buyer is exposed. Third, two buyers with different capital costs will bid genuinely different numbers on identical information, which is why offers vary between buyers even in a competitive process.
Input One: Life Expectancy, and Why It Dominates
Life expectancy underwriting is a distinct industry. Buyers commission reports from independent firms — the names that appear most often in this market include ITM TwentyFirst, Fasano Associates, AVS Underwriting, and Predictive Resources — each of which reviews the insured’s medical records and produces a mortality assessment.
The output is usually two numbers. The median life expectancy is expressed in months: the point at which half of a comparable cohort would be expected to have died. The mortality multiplier is the more informative figure — it states how much faster than a standard population the insured is expected to die. A multiplier of 200% means roughly twice standard mortality. The baseline is an industry mortality table, most commonly the Society of Actuaries 2015 Valuation Basic Table, which replaced the 2008 VBT as the standard reference for this purpose.
Two reports on the same person routinely differ, sometimes by more than a year, because underwriters weight comorbidities and functional status differently. Many buyers commission two and blend them; some use the longer of the two, which is not in the seller’s favor. If the reports diverge badly, that is worth surfacing rather than accepting — see what to do when two LE reports disagree and how to read the report itself.
The uncomfortable truth in this input: better health means a lower offer. A seller in robust condition for their age will receive less than an identically-sized policy on an impaired life, and no amount of negotiation changes that. Life expectancy underwriting and the VBT mortality table cover the mechanics in detail.
Input Two: Carrying Cost, the Variable You Control
This is where sellers leave money behind. The premium a buyer models is not the premium you have been paying. It is the minimum required to keep the policy in force through the modeled period — a process the industry calls premium optimization.
On a universal life policy, the carrier deducts monthly cost of insurance charges and expense loads from the accumulation value, and any premium beyond what those deductions require is simply building cash value. A buyer does not want cash value; they want the death benefit. So they model funding the policy at the minimum level that avoids lapse, which on an older UL contract can be a fraction of the scheduled premium — or, on a badly performing contract with rising cost of insurance charges, considerably more.
That is why the in-force illustration is the single most important document in pricing. Request it from the carrier and specify the scenarios: minimum premium to carry the policy to age 95, to age 100, and to the contract’s maturity date, plus a column showing cost of insurance charges. Carriers typically take two to four weeks. Why the in-force illustration matters explains what to ask for.
Policy structure drives this too. A guaranteed universal life policy with a no-lapse guarantee has a contractual minimum premium that must be paid on schedule to preserve the guarantee — predictable, and generally attractive to buyers. A whole life policy with substantial cash value and paid-up additions can sometimes be carried by its own dividends. An indexed universal life policy with rising cost of insurance charges and a collapsing account value is expensive to carry and prices accordingly.
| Input | Source | Effect on Offer | Can You Influence It? |
|---|---|---|---|
| Net death benefit | Policy, less loans and assignments | Directly proportional | Only by repaying or releasing a loan |
| Life expectancy | Independent LE underwriter, 2015 VBT basis | Shorter LE raises the offer | No; but ensure records are complete and current |
| Carrying cost | Carrier in-force illustration | Lower cost raises the offer | Yes; request minimum-premium scenarios |
| Buyer’s target return | Fund mandate and cost of capital | Higher target lowers the offer | Only by shopping to multiple buyers |
| Policy type | Contract | Predictable premiums price better | No |
| Carrier strength | Ratings agencies | Minor effect on some buyers | No |
Input Three: The Net Death Benefit, Not the Face Amount
Buyers price the amount the carrier will actually pay, which is often less than the number on the cover page.
Outstanding policy loans reduce the death benefit dollar for dollar, plus accrued loan interest. A $500,000 policy with a $140,000 loan is a $360,000 asset. Loans do not disqualify a policy, but they change the arithmetic completely, and a loan that has been compounding for fifteen years is often far larger than the owner remembers.
Other deductions apply as well. A collateral assignment to a bank must be released before closing. An accelerated death benefit already taken reduces the remainder. Some policies carry a return-of-premium or term rider that expires on a schedule. Riders that add benefit at death — accidental death riders, for example — are generally ignored by buyers, because a buyer will not price an event that may not occur.
The face amount is also the gate. Below roughly $100,000 of net death benefit, the fixed transaction costs of medical retrieval, life expectancy reports, escrow, and legal review consume any plausible spread, and buyers decline rather than bid. That threshold is economic, not a policy preference.
Input Four: The Buyer’s Required Return
Institutional buyers in this market are funding purchases with capital that has expectations attached — pension funds, insurance-linked securities funds, family offices, specialty credit funds. Their targeted internal rate of return on a portfolio of policies has historically sat in the low-to-mid teens, reflecting the illiquidity, the mortality uncertainty, and the ongoing premium obligation.
That target is not negotiable at the individual-policy level. What varies is which buyer is looking. Different funds have different mandates: some want short life expectancies, some want large face amounts, some are constrained by carrier concentration limits, and some are filling a specific duration bucket in a portfolio. A policy that is a poor fit for one fund’s book can be an excellent fit for another’s, which is exactly why shopping a policy to multiple buyers produces different numbers on identical information.
There is also a resale market — the tertiary market — where existing policies trade between institutional holders. Its existence supports pricing in the primary secondary market, because buyers know they have an exit.
What all of this means practically: a single offer tells you almost nothing about value. Two or three offers on the same underwriting file tell you a great deal.
What This Means for Your Own Policy
Run through the four inputs against your own facts and you can predict the shape of the answer before anyone quotes you.
A 78-year-old with congestive heart failure, a $750,000 guaranteed universal life policy with a modest guaranteed premium and no loans, is close to the ideal case: large net benefit, impaired mortality, low and predictable carrying cost. A 66-year-old marathon runner with a $250,000 indexed universal life policy whose cost of insurance charges are climbing is the opposite: long projected life expectancy and expensive to carry. Both are real policies. Only one will attract competitive bids. What makes a policy attractive to buyers works through more examples.
The federal Government Accountability Office study of this market, GAO-10-775, found that policyholders who sold typically received in the range of roughly 10% to 35% of face value, and several multiples of what the same policies would have returned on surrender. The width of that band is the four inputs above doing their work.
Every Alternative Priced Against the Offer — and When Not to Sell
An offer only means something in comparison. Put all of these on one page before deciding.
Keep paying. The death benefit generally passes to beneficiaries income-tax-free under Internal Revenue Code section 101(a) at full value. No offer matches that if someone needs the money.
Surrender. Take cash surrender value now. Gain above cost basis is ordinary income. This is the floor an offer must beat, and on healthy insureds with small policies it frequently wins.
Reduced paid-up. Trade cash value for a smaller fully paid policy. Zero cash today, no premium ever again. Often the right answer when the real problem is affordability.
Extended term. Full face amount for a limited number of years, no more premiums.
1035 exchange. Move cash value into another life policy or annuity with no current tax. Fixes a product problem.
Accelerated death benefit. If the rider exists and the insured qualifies, this pays without fees or a buyer. Payments to a terminally or chronically ill insured are generally excluded from income under section 101(g).
Life settlement. Correct only when it beats every line above it after tax.
Selling is the wrong answer when a beneficiary still needs the coverage; when the net death benefit is under roughly $100,000 and the honest expectation is no offers at all; when the insured is in strong health for their age, because a long projected life expectancy compresses offers toward surrender value; when a rider already in the contract would pay faster and cheaper; when the proceeds would end SSI or Medicaid eligibility, both asset-tested, with SSI counting resources above $2,000 for an individual since 1989; and when only one buyer has looked at the file. A single unshopped offer is not a price. It is a starting position.
To find out where your own policy sits in the four inputs, send the policy cover page for a free, no-obligation review, or call (732) 978-9575. Further reading: the buyer pricing overview and what affects an offer. Pine Lake Legacy provides educational information only and does not provide legal, tax, or investment advice.
Frequently Asked Questions
What is the single biggest driver of my offer?
Projected life expectancy, because it determines both when the death benefit arrives and how many premiums the buyer must pay in the meantime. It is produced by an independent underwriter from your medical records, benchmarked against an industry table such as the Society of Actuaries 2015 Valuation Basic Table.
Why does good health mean a lower offer?
Because the buyer must pay premiums for longer before the death benefit arrives, which reduces the return on any given purchase price. It is a genuinely uncomfortable feature of this market and it is not negotiable. A healthy insured with a small policy is often better served by surrender or reduced paid-up.
What can I actually do to increase my offer?
Request an in-force illustration from the carrier showing the minimum premium required to carry the policy to ages 95 and 100. Buyers model minimum funding, not what you have been paying, and a policy that can be carried cheaply is worth more. Also make sure your medical records are complete and current.
Does an outstanding policy loan disqualify me?
No, but it reduces what a buyer is buying. A loan cuts the death benefit dollar for dollar plus accrued interest, so a $500,000 policy with a $140,000 loan is priced as a $360,000 asset. Get the current loan payoff figure from the carrier before shopping, since compounding interest surprises most owners.
Why do two buyers quote different numbers on the same policy?
Different funds have different costs of capital, different mandates on life expectancy and face amount, and different concentration limits by carrier. A policy that is a poor fit for one book can fill a gap in another. This is why a single offer tells you little and two or three tell you a great deal.
What return are buyers targeting?
Institutional buyers in this market have historically targeted internal rates of return in the low-to-mid teens, reflecting illiquidity, mortality uncertainty, and the ongoing premium obligation. That hurdle is set by their investors and is not negotiable on an individual policy. What you can change is how many buyers see the file.
How does an offer compare to surrender value?
Surrender value is the floor any offer must beat. Federal research (GAO-10-775) found sellers typically received roughly 10% to 35% of face value and several multiples of surrender value, but that is a historical average across very different policies. On a healthy insured with a small policy, surrender sometimes wins outright.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- How Life Settlement Buyers Price A Policy
- What Is Life Expectancy Underwriting
- What Is The Vbt Mortality Table
- What Affects A Life Settlement Offer
- What Is An In Force Illustration
- Life Expectancy Report Explained
- Two Le Reports Differ
- What Makes A Policy Attractive
- Why Life Settlement Offers Vary Between Buyers
Pine Lake Legacy does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.